BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17244214)

  • 1. Frequency-doubling technology: searching for the optimum diagnostic criteria for glaucoma.
    Ferreras A; Larrosa JM; Polo V; Pajarín AB; Mayoral F; Honrubia FM
    Acta Ophthalmol Scand; 2007 Feb; 85(1):73-9. PubMed ID: 17244214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, SITA Standard and SITA Fast perimetry in perimetrically inexperienced individuals.
    Pierre-Filho Pde T; Schimiti RB; de Vasconcellos JP; Costa VP
    Acta Ophthalmol Scand; 2006 Jun; 84(3):345-50. PubMed ID: 16704696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?
    Ferreras A; Polo V; Larrosa JM; Pablo LE; Pajarin AB; Pueyo V; Honrubia FM
    J Glaucoma; 2007; 16(4):372-83. PubMed ID: 17571000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency doubling perimetry and short-wavelength automated perimetry to detect early glaucoma.
    Leeprechanon N; Giaconi JA; Manassakorn A; Hoffman D; Caprioli J
    Ophthalmology; 2007 May; 114(5):931-7. PubMed ID: 17397926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients.
    Horn FK; Wakili N; Jünemann AM; Korth M
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
    Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
    J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma: a comparison between different test programs.
    Bengtsson B; Heijl A
    Ophthalmology; 2006 Jul; 113(7):1092-7. PubMed ID: 16815399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.
    Artes PH; Hutchison DM; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2451-7. PubMed ID: 15980235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of SITA and full-threshold standard perimetry to frequency-doubling technology perimetry in glaucoma.
    Boden C; Pascual J; Medeiros FA; Aihara M; Weinreb RN; Sample PA
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2433-9. PubMed ID: 15980232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study.
    Haymes SA; Hutchison DM; McCormick TA; Varma DK; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):547-54. PubMed ID: 15671281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of test duration as a screening criterion for frequency doubling perimetry.
    Thomas R; Parikh R; Muliyil J; Bhat S; George R
    Am J Ophthalmol; 2004 Mar; 137(3):562-3. PubMed ID: 15013885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability components of standard automated perimetry and frequency-doubling technology perimetry.
    Spry PG; Johnson CA; McKendrick AM; Turpin A
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1404-10. PubMed ID: 11328758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detectability of glaucomatous changes using SAP, FDT, flicker perimetry, and OCT.
    Nomoto H; Matsumoto C; Takada S; Hashimoto S; Arimura E; Okuyama S; Shimomura Y
    J Glaucoma; 2009 Feb; 18(2):165-71. PubMed ID: 19225357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes on glaucoma screening using frequency-doubling perimetry.
    Realini T; Lai MQ; Barber L
    Ophthalmology; 2004 Nov; 111(11):2133-6. PubMed ID: 15522382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for glaucomatous visual field loss with frequency-doubling perimetry.
    Johnson CA; Samuels SJ
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):413-25. PubMed ID: 9040475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Groningen Longitudinal Glaucoma Study. I. Baseline sensitivity and specificity of the frequency doubling perimeter and the GDx nerve fibre analyser.
    Heeg GP; Blanksma LJ; Hardus PL; Jansonius NM
    Acta Ophthalmol Scand; 2005 Feb; 83(1):46-52. PubMed ID: 15715556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.